Home/Federal Circuit/Watson Pharmaceuticals, Inc. v. Schwetz

Watson Pharmaceuticals, Inc. v. Schwetz

38 F. App'x 578
Court of Appeals for the Federal Circuit·Decided May 20, 2002·No. No. 01-1285·Published

Opinion

ON MOTION

ORDER

Bristol-Myers Squibb Co., Watson Pharmaceuticals, Inc. and Danbury Phar-macal, Inc. move jointly to voluntarily dismiss with prejudice. The Acting Principal Deputy Commissioner consents.

Upon consideration thereof,

IT IS ORDERED THAT:

(1) The unopposed motion to dismiss is granted.

(2) The motion to transfer is moot.

(3) All sides shall bear their own costs.

Free access — add to your briefcase to read the full text and ask questions with AI

Watson Pharmaceuticals, Inc. v. Schwetz, 38 F. App'x 578 (Fed. Cir. 2002).

38 F. App'x 578 (Watson Pharmaceuticals, Inc. v. Schwetz) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.